Vés al contingut

A phase 1 first-in-human study evaluating safety, pharmacokinetics, and efficacy of ABBV-969 in adult subjects with metastatic castration-resistant prostate cancer.

Obert
  • Codi protocol: M24-742
  • Codi EudraCT: _
  • Servei: Sense classificar
  • Investigador/a principal:  Valderrama Rodríguez, Angelica
  • Malaltia: Tumors
  • Fase: Fase I